Building on NIH research, we are developing a patent pending pharmaceutical for treatment of pain, without the risks seen with opioids or NSAIDs.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free